Diva Laboratories, a medical display unit of Taiwan’s Qisda Corp., is expanding with three growth drivers: the world’s first 55- and 65-inch optical bonding (OB) LCDs for operating rooms, a QDII off-the-shelf display line set for mass production in October, and OLED panels tailored for ultrasound imaging. Shipments of the large OB displays started in July, while OLED models are scheduled to roll out in late 2025 and scale in 2026.

Phison Electronics reported a sharp decline in second-quarter 2025 profit as steep exchange-rate fluctuations eroded earnings, even as revenue climbed on stronger NAND pricing. Net profit fell 34.7% from the previous quarter to NT$745 million (US$24.82 million), with currency losses of NT$1.345 billion accounting for about 7.5% of operating revenue. Revenue rose 29.3% sequentially and 12.6% year-over-year to NT$17.89 billion, while gross margin narrowed to 29.1%.

As Nvidia’s H20 artificial intelligence (AI) chips become a focal point in US-China tech competition, Beijing is taking a cautious and increasingly assertive approach toward their use domestically. The move underscores China’s broader strategy to reduce reliance on foreign technology while strengthening its own semiconductor industry.

Empyrean Technology Co., one of China’s leading EDA software developers, posted first-half 2025 revenue of CNY502 million (approx. US$70 million), up 13% from a year earlier. However, net profit attributable to shareholders plunged 91.9% to CNY3.07 million, while adjusted net profit excluding non-recurring items registered a loss of CNY18.62 million. Earnings per share stood at CNY0.0057. The company said it would not pay dividends, issue bonus shares, or convert reserves into equity.